T-Cellular immunotherapy is at the cutting edge for cancer treatment. Kite Pharma is currently the front-runner in the field of immune cell therapy for cancer.
Fosun Pharma’s business covers the whole healthcare industry chain. Fosun Pharma maintains a nationally recognized enterprise technology center and a highly capable internationally R&D team. The cooperation between Kite and Fosun will bring the world-leading cell therapies to China.